Reaction Details |
![](/images/Email.png) | Report a problem with these data |
Target | Cytochrome P450 3A4 |
---|
Ligand | BDBM50505820 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_1824176 (CHEMBL4323940) |
---|
IC50 | >100000±n/a nM |
---|
Citation | Yang, T; Hu, M; Qi, W; Yang, Z; Tang, M; He, J; Chen, Y; Bai, P; Yuan, X; Zhang, C; Liu, K; Lu, Y; Xiang, M; Chen, L Discovery of Potent and Orally Effective Dual Janus Kinase 2/FLT3 Inhibitors for the Treatment of Acute Myelogenous Leukemia and Myeloproliferative Neoplasms. J Med Chem62:10305-10320 (2019) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Cytochrome P450 3A4 |
---|
Name: | Cytochrome P450 3A4 |
Synonyms: | Albendazole monooxygenase | Albendazole sulfoxidase | CP3A4_HUMAN | CYP3A3 | CYP3A4 | CYPIIIA3 | CYPIIIA4 | Cytochrome P450 3A3 | Cytochrome P450 3A4 (CYP3A4) | Cytochrome P450 HLp | Nifedipine oxidase | Quinine 3-monooxygenase | Taurochenodeoxycholate 6-alpha-hydroxylase |
Type: | Enzyme |
Mol. Mass.: | 57349.57 |
Organism: | Homo sapiens (Human) |
Description: | n/a |
Residue: | 503 |
Sequence: | MALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMF
DMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISI
AEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYS
MDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICV
FPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSI
IFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVV
NETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFS
KKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLG
GLLQPEKPVVLKVESRDGTVSGA
|
|
|
BDBM50505820 |
---|
n/a |
---|
Name | BDBM50505820 |
Synonyms: | CHEMBL4436572 |
Type | Small organic molecule |
Emp. Form. | C27H38FN7 |
Mol. Mass. | 479.6359 |
SMILES | CCCCN(C)C1CCN(CC1)c1ccc(Nc2ncc(C)c(n2)-c2cnn(c2)C(C)C)cc1F |
Structure |
|